Cancer Plus (CP) is a quarterly journal dedicated to the publication of findings in cancer research. This journal is a joint collaboration between Shanxi Academy of Medical Sciences and Shanxi Bethune Hospital (China). We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions, e.g. original research papers and review articles.
Cancer Plus covers subject areas, including but not limited to the following:
- Mechanisms of tumorigenesis
- Genetic alterations of cancer
- Epigenetics of cancer
- Cell signalling
- Cancer stem cells
- Cancer prevention
- Diagnosis
- Cancer drugs/chemotherapy/therapeutic methods
- Clinical trials
We welcome researchers and scholars in related fields to submit manuscripts to CP, and we especially encourage multidisciplinary team or department collaborations. CP upholds high publishing standards and adheres to rigorous peer reviews before acceptance. Potential authors are encouraged to make submissions through the online submission system:
https://www.accscience.com/journal/CP
If you have any question about submissions and publications, please contact the Editorial Office at cp.office@accscience.sg
Warm Regards,
Editorial Office
Cancer Plus
AccScience Publishing
https://www.accscience.com/